The company’s board of directors add that “there is no assurance that a transaction will take place”.
Future announcements are expected to follow subject to material developments, says the board of directors.
On July 15, the company reported earnings of $8.6 million in 1HFY2024 ended June 30, down 31.1% y-o-y in 1HFY2023. Revenue in the same period was down 12.4% y-o-y at $33.1 million.
TalkMed was listed in 2014, with its IPO shares priced at 20 cents each. Its shares surged to an all-time high of 89 cents in 2017.
See also: LMS Compliance completes acquisition of 75% stake in Anchor Technology Holdings
Shares in TalkMed closed 0.5 cents lower, or down 1.24%, at 40 cents on Sept 19.
Scroll to continue
